Hyperlipidaemia and cardiovascular disease

Current Opinion in Lipidology

Volumn 13, Issue 2, 2002, Pages 227-229

  Cozma, Lawrence S ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; EDITORIAL; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; SMOKING;

CARDIOVASCULAR DISEASES; CHOLESTEROL; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS;

EID: 0036212622     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200204000-00016     Document Type: Editorial

References (17)

1. Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?
2. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)
3. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment
4. Secondary prevention: Is inpatient rehabilitation effective or are lifestyle changes to be replaced by drugs?
5. Nutrition and physical activity interventions to reduce cardiovascular disease risk in health care settings: A quantitative review with a focus on women
6. Dietary antioxidants and peripheral arterial disease: The Rotterdam Study
7. Effect of cholesterol-lowering therapy on endothelial function
8. Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction
9. Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men
10. Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men
11. Plasma lipoproteins, hemostasis and thrombosis
12. Diabetes and cardiovascular disease. The Framingham study
13. Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women
14. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
15. The effect of hormone replacement therapy on cardiovascular risk factors in type 2 diabetes: A randomized controlled trial
16. Insulin resistance and hypersecretion in obesity
17. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women